Top

World Journal of Urology

Published in:

01-04-2015 | Letter to the Editor

Thulium laser for the treatment of upper urinary tract carcinoma (UTUC)? Are we there, yet?

Authors: Esteban Emiliani, Thomas R. W. Herrmann, Alberto Breda

Published in: World Journal of Urology | Issue 4/2015

Excerpt

Dear Editor, …

Rouprêt M, Babjuk M, Compérat E et al (2013) European association of urology. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63(6):1059–1071. doi:10.1016/j.eururo.2013.03.032 CrossRefPubMed

Johnson GB, Grasso M (2005) Ureteroscopic management of upper urinary tract transitional cell carcinoma. Curr Opin Urol 15:89–93CrossRefPubMed

Cutress ML, Stewart GD, Wells-Cole S et al (2012) Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int 110(11):1608–1617. doi:10.1111/j.1464-410X.2012.11169.x CrossRefPubMed

Adamis S, Varkarakis J (2011) Minimally invasive approach in the management of upper-urinary-tract tumours. Scand J Urol Nephrol 45(6):381–387. doi:10.3109/00365599.2011.590999 CrossRefPubMed

Fajkovic H, Klatte T, Nagele U et al (2013) Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience. World J Urol 31(1):37–44. doi:10.1007/s00345-012-0948-4 CrossRefPubMed

Pak RW, Moskowitz EJ, Bagley DH (2009) What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival. J Endourol 23:341–346. doi:10.1089/end.2008.0251 CrossRefPubMed

Chen GL, Bagley DH (2001) Ureteroscopic surgery for upper tract transitional cell carcinoma: complications and management. J Endourol 15:399–404CrossRefPubMed

Cornu JN, Rouprêt M, Carpentier X et al (2010) Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol 28(2):151–156. doi:10.1007/s00345-009-0494-x CrossRefPubMed

Bader M, Sroka R, Gratzke C et al (2009) Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol 56(1):65–71. doi:10.1016/j.eururo.2008.12.012 CrossRefPubMed

10.

Oelke M, Bachmann A, Descazeaud A (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64(1):118–140. doi:10.1016/j.eururo.2013.03.004 CrossRefPubMed

11.

Gao X, Ren S, Xu C et al (2008) Thulium laser resection via a flexible cystoscope for recurrent non-muscle invasive bladder cancer: initial clinical experience. BJU Int 102:1115–1118CrossRefPubMed

12.

Muto G, Collura D, Giacobbe A et al (2014) Thulium: yttrium-aluminum garnet laser for En Bloc Resection of Bladder Cancer: clinical and histopathologic advantages. Urology 83:851–855CrossRefPubMed

13.

Kramer MW, Abdelkawi IF, Wolters M, Bach T, Gross AJ, Nagele U, Conort P, Merseburger AS, Kuczyk MA, Herrmann TR (2014) Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancer. Minim Invasive Ther Allied Technol 23(4):206–213CrossRefPubMed

14.

Kramer MW, Wolters M, Cash H, Jutzi S, Imkamp F, Kuczyk MA, Merseburger AS, Herrmann TR (2014) Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer. World J Urol. doi:10.1007/s00345-014-1337-y

15.

Bach T, Huck N, Wezel F et al (2010) 70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex vivo evaluation. BJU Int 106(3):368–372. doi:10.1111/j.1464-410X.2009.09059.x CrossRefPubMed

16.

Fried NM, Murray KE (2005) High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol 19:25–31CrossRefPubMed

17.

Teichmann HO, Herrmann TR, Bach T (2007) Technical aspects of lasers in urology. World J Urol 25(3):221–225CrossRefPubMed

18.

Marks AJ, Teichmann JMH (2007) Laser in clinical urology: state of the art and new horizons. World J Urol 25:227–233CrossRefPubMed

19.

Defidio L, De Dominicis M, Gianfrancesco Di et al (2011) First collaborative experience with thulium laser ablation of localized upper urinary tract urothelial tumors using retrograde intra-renal surgery. Arch Ital Urol Androl 83(3):147–153PubMed

20.

LisaLaser^® USA Revolix^® information sheet. http://www.lisalaserusa.com/urology/. Accessed 22 Nov 2014

21.

F.D.A access data, 510(k) summary of safety and effectiveness information according 21 CFR Part 807.87(h). Indication of use of vela^®XL laser system. http://www.accessdata.fda.gov/cdrh_docs/pdf10/K103654.pdf. Accessed 22 Nov 2014

22.

F.D.A access data (2013) Attachment V, 510 (k) summary. Indication of use of RevoLix Jr, RevoLix 120 watt and Quanta Cyber TM 150. http://www.accessdata.fda.gov/cdrh_docs/pdf11/k110941.pdf. Accessed 20 Nov 2014

Title: Thulium laser for the treatment of upper urinary tract carcinoma (UTUC)? Are we there, yet?
Authors: Esteban Emiliani
Thomas R. W. Herrmann
Alberto Breda
Publication date: 01-04-2015
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 4/2015
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-015-1511-x

At a glance: The STEP trials

Springer Medicine

Thulium laser for the treatment of upper urinary tract carcinoma (UTUC)? Are we there, yet?

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2015

Re: World J Urol. 2014 Nov 22. [Epub ahead of print]. HoLEP has come of age. Vincent MW, Gilling PJ

Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014

T. R. W. Herrmann and T. Bach (eds.): Editorial comment on “What is relevant for Lasers in Urology?”

En bloc resection of urothelial cancer within the urinary bladder: the upcoming gold standard?

Current evidence on lasers in laparoscopy: partial nephrectomy

Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement